Cartesian Therapeutics Inc (RNAC)
26.41
+0.07
(+0.27%)
USD |
NASDAQ |
May 17, 16:00
26.41
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Market Cap: 470.35M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 470.35M |
| May 16, 2024 | 468.75M |
| May 15, 2024 | 474.27M |
| May 14, 2024 | 440.45M |
| May 13, 2024 | 381.73M |
| May 10, 2024 | 376.74M |
| May 09, 2024 | 389.02M |
| May 08, 2024 | 413.76M |
| May 07, 2024 | 412.96M |
| May 06, 2024 | 458.07M |
| May 03, 2024 | 455.58M |
| May 02, 2024 | 434.76M |
| May 01, 2024 | 402.90M |
| April 30, 2024 | 392.76M |
| April 29, 2024 | 391.51M |
| April 26, 2024 | 374.25M |
| April 25, 2024 | 371.94M |
| April 24, 2024 | 368.74M |
| April 23, 2024 | 366.42M |
| April 22, 2024 | 324.96M |
| April 19, 2024 | 318.73M |
| April 18, 2024 | 307.52M |
| April 17, 2024 | 328.93M |
| April 16, 2024 | 333.73M |
| April 15, 2024 | 337.64M |
| Date | Value |
|---|---|
| April 12, 2024 | 344.75M |
| April 11, 2024 | 320.75M |
| April 10, 2024 | 290.17M |
| April 09, 2024 | 248.74M |
| April 08, 2024 | 233.27M |
| April 05, 2024 | 73.42M |
| April 04, 2024 | 83.42M |
| April 03, 2024 | 81.10M |
| April 02, 2024 | 87.72M |
| April 01, 2024 | 92.68M |
| March 28, 2024 | 107.56M |
| March 27, 2024 | 106.95M |
| March 26, 2024 | 101.09M |
| March 25, 2024 | 110.13M |
| March 22, 2024 | 115.66M |
| March 21, 2024 | 113.98M |
| March 20, 2024 | 124.59M |
| March 19, 2024 | 116.47M |
| March 18, 2024 | 102.34M |
| March 15, 2024 | 93.98M |
| March 14, 2024 | 86.69M |
| March 13, 2024 | 89.07M |
| March 12, 2024 | 95.24M |
| March 11, 2024 | 103.49M |
| March 08, 2024 | 103.65M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
63.62M
Minimum
Nov 20 2019
567.10M
Maximum
Jun 14 2021
253.32M
Average
237.22M
Median
Jan 12 2023
Market Cap Benchmarks
| Marinus Pharmaceuticals Inc | 73.06M |
| Adial Pharmaceuticals Inc | 6.285M |
| Poseida Therapeutics Inc | 309.30M |
| Biomea Fusion Inc | 439.96M |
| NovaBay Pharmaceuticals Inc | 4.487M |
Market Cap Related Metrics
| PS Ratio | 5.352 |
| PEG Ratio | -0.0005 |
| Price | 26.41 |
| Earnings Yield | -212.3% |
| PEGY Ratio | -0.0005 |